When you’re entrusted with developing therapeutics for challenging or undruggable targets, it’s a struggle to characterize molecular interactions. And it’s not for lack of effort or expertise — SPR and other methods have either failed or have given noisy, unreliable affinity data. When it’s not clear which hits to advance, the pressure is on and you feel you are running out of options.
Watch this online event to discover how Dianthus — a plate-based affinity screening platform with breakthrough Spectral Shift technology — removes the limitations that get in the way of your screening campaign's success.
In this event you will:
- Learn how to finally move your screening campaigns forward with direct affinity measurements in solution and reduced assay development
- See data from case studies using Dianthus for challenging applications like PROTACs ternary complex, hook effect, and undruggable KRAS
- Take a tour of Dianthus to learn about assay setup and get a quick peek into single-point screening data analysis